Sign in Subscribe
Cardiology

QMed's Disease Management Programs Show Significant Reduction in Hypertension

Strategic Insights

— 2 min read

QMed, Inc., a company that provides Disease Management (DM) services to patients and physicians around the country, has announced that its programs have successfully reduced hypertension among health plan members, including many managed Medicare seniors. With nearly 58% of hypertensive patients in QMed programs maintaining normal blood pressure ranges, the company's results significantly surpass those of a recent study, which cited a 72% success rate in maintaining normal blood pressure. This achievement is particularly noteworthy considering the resurgence of hypertension since 1990, a trend that has been exacerbated by the aging U.S. population and the growing obesity epidemic. The study, published in Hypertension: Journal of the American Heart Association, reveals that nearly 65 million adult Americans suffer from hypertension, a 30% increase in the last 10 years alone.

Key Takeaways:

  • QMed's Disease Management programs have significantly reduced hypertension among health plan members, with nearly 58% of hypertensive patients maintaining normal blood pressure ranges.
  • This achievement surpasses the success rate of a recent study, which cited a 72% success rate in maintaining normal blood pressure.
  • QMed's model has produced long-term performance, with 89% of participating physicians using the company's recommendations to optimize blood pressure medications.
  • The program's success has significant implications for the entire healthcare system and is driving the company's rapid growth.
  • Hypertension remains a growing threat, with nearly 65 million adult Americans suffering from the condition, a 30% increase in the last 10 years alone.
  • Nearly 31.3% of American adults have high blood pressure, but only 33% of those with the condition have it under control.
  • QMed's Disease Management programs have achieved success despite the resurgence of hypertension since 1990.
  • The company's model, which incorporates data analysis and physician engagement, has been key to delivering evidence-based best practice medicine and improving patient compliance.

Statistics:

  • 58% of hypertensive patients in QMed programs maintain normal blood pressure ranges.
  • 72% above figures cited in a recent study, indicating a significant reduction in hypertension.
  • 65 million adult Americans suffer from hypertension, a 30% increase in the last 10 years alone.
  • 31.3% of American adults have high blood pressure.
  • 33% of those with high blood pressure have it under control.
  • 89% of physicians engaged in QMed programs use the company's recommendations to optimize blood pressure medications.
  • QMed's Disease Management programs have achieved significant health and financial results, demonstrating a promising approach to managing hypertension and improving patient outcomes.

Sources:

  • NewsRx.com & NewsRx.net, "QMed, Inc. Announces Disease Management Results," September 26, 2004.
  • Hypertension: Journal of the American Heart Association, "Prevalence and Control of Hypertension in the United States," no date.
  • Heart Disease Weekly, "QMed's Disease Management Programs Show Significant Reduction in Hypertension," September 26, 2004.

Read more